PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Risk of gastrointestinal adverse events associated with glucagon-like peptide-1 receptor agonists for weight loss

JAMA

2023-10-05
(Press-News.org)

About The Study: This study found that use of glucagon-like peptide-1 agonists for weight loss compared with use of bupropion-naltrexone was associated with increased risk of pancreatitis, gastroparesis, and bowel obstruction but not biliary disease. Given the wide use of these drugs, these adverse events, although rare, must be considered by patients who are contemplating using the drugs for weight loss because the risk-benefit calculus for this group might differ from that of those who use them for diabetes. 

Authors: Mahyar Etminan, Pharm.D., M.Sc., of the University of British Columbia in Vancouver, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jama.2023.19574)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.19574?guestAccessKey=31a6dd82-d1ee-46d6-b95e-e4ef621c2ddf&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=100523

 

END



ELSE PRESS RELEASES FROM THIS DATE:

UK study shows hybrid closed-loop technology improved maternal glucose levels during pregnancy complicated by type 1 diabetes

2023-10-05
For pregnant women with type 1 diabetes, a technology giving insulin doses, as informed by a smartphone algorithm, helps them better manage their blood sugars compared with traditional insulin pumps or multiple daily injections, according to a new randomised trial published in The New England Journal of Medicine (NEJM) and presented at the European Association for the Study of Diabetes (EASD) meeting in Hamburg (2-6 October). Despite better systems for monitoring blood sugars and delivering insulin, hormonal changes and altered eating patterns during pregnancy mean that ...

Successful morphing of inorganic perovskites without damaging their functional properties

Successful morphing of inorganic perovskites without damaging their functional properties
2023-10-05
A research team co-led by scholars from City University of Hong Kong (CityU) has successfully morphed all-inorganic perovskites at room temperature without compromising their functional properties. Their findings demonstrate the potential of this class of semiconductors for manufacturing next-generation deformable electronics and energy systems in the future. All-inorganic lead halide perovskites are becoming increasingly important semiconducting materials in energy conversion and optoelectronics because of their outstanding performance and enhanced environmental stability. “However, unlike metal ...

MD Anderson launches collaborative initiative to reduce breast cancer disparities in Houston area

MD Anderson launches collaborative initiative to reduce breast cancer disparities in Houston area
2023-10-05
HOUSTON ― The University of Texas MD Anderson Cancer Center today announced the launch of Texas Health Equity Alliance for Breast Cancer (THEAL), a community-wide health care initiative to reduce breast cancer disparities in the Houston area, particularly for Black women.  THEAL builds upon the expertise of MD Anderson’s Department of Health Disparities Research in addressing the determinants of cancer disparities while leveraging the cancer prevention and control platform’s experience in leading cross-sector collaboratives ...

In checking chess’s gender bias, researchers find parents and mentors shortchange girls’ potential

2023-10-05
“The Queen’s Gambit” miniseries portrayed the life of a fictional chess prodigy, Beth Harmon, who is continuously underestimated in male-dominated competitions. A team of New York University psychology researchers has now found some “real-life” evidence of what Harmon faced as a younger player: Parents and coaches of youth chess players peg the highest potential rating of girl players to be lower than that of boy players. Moreover, the study’s authors, who included Jennifer Shahade, a two-time US Women’s Chess champion, found ...

Female chess players may experience gender bias from parents, mentors

2023-10-05
Young female chess players often face gender bias both in the male-dominated chess world and among parents and mentors who believe girls have less potential to succeed in chess than boys, according to research published by the American Psychological Association.   “It’s disheartening to see young female players’ potential downgraded, even by the people who are closest to them, like their parents and coaches,” said lead researcher Sophie Arnold, a doctoral student at New York University.  The study, which was published online in the Journal of Experimental Psychology: General, presents what the researchers say is the first large-scale ...

US cancer centers continue to see chemotherapy shortages, according to update from NCCN

2023-10-05
PLYMOUTH MEETING, PA [October 5, 2023] — The National Comprehensive Cancer Network® (NCCN®)—a non-profit alliance of leading cancer centers across the United States—has released a follow-up survey on the ongoing chemotherapy shortages: 72% of the centers surveyed continue to experience a shortage of carboplatin and 59% are still seeing a shortage of cisplatin. Overall, 86% of centers surveyed reported experiencing a shortage of at least one type of anti-cancer drug. View the updated survey results at NCCN.org/platinum-update. The NCCN Best Practices Committee originally shared survey results ...

Announcing 2023 Glenn Foundation for Medical Research and AFAR Research Grants for Junior Faculty

Announcing 2023 Glenn Foundation for Medical Research and AFAR Research Grants for Junior Faculty
2023-10-05
NEW YORK, NY and SANTA BARBARA, CA – The American Federation for Aging Research (AFAR) and the Glenn Foundation for Medical Research are pleased to announce the 2023 Glenn Foundation for Medical Research and AFAR Research Grants for Junior Faculty recipients. The Research Grant for Junior Faculty provides an early career investigator with up to $150,000 for one to two ...

UNIST student startup sets new global standard for companion animal pet registration

UNIST student startup sets new global standard for companion animal pet registration
2023-10-05
Pireco Co., Ltd., a student-led venture company of UNIST, has accomplished a remarkable feat in establishing an international standard for their multi-biometrics identification solution designed for companion animals. This groundbreaking solution simplifies the process of accurately identifying and registering companion animals by simply scanning the distinctive patterns of ridges and creases on their noses using smartphones. The advent of this pioneering technology sets the stage for global registration ...

How much are you willing to pay for a product or service? It depends on your other options and the given context

2023-10-05
Researchers from Concordia University and Northwestern University published a new Journal of Marketing study that presents the Comparative Method of Valuation as a more accurate way to measure customers’ willingness to pay for a product or service. The study, forthcoming in the Journal of Marketing, is titled “Measuring Willingness to Pay: A Comparative Method of Valuation” and is authored by Sharlene He, Eric T. Anderson, and Derek D. Rucker. At the grocery store, a customer may be willing to pay $18 for a bottle of Riesling when comparing it to a $15 bottle ...

Alliance for Clinical Trials in Oncology study shows promise for patients with muscle-invasive urothelial carcinoma

Alliance for Clinical Trials in Oncology study shows promise for patients with muscle-invasive urothelial carcinoma
2023-10-05
The Alliance for Clinical Trials in Oncology today announced that the Alliance Data and Safety Monitoring Board (DSMB) determined that the phase III AMBASSADOR (A031501) trial met one of its dual primary endpoints of disease-free survival (DFS) for the adjuvant treatment of patients with localized muscle-invasive urothelial carcinoma (MIUC) and locally advanced urothelial carcinoma. At a pre-specified interim analysis review, pembrolizumab demonstrated a statistically significant and clinically meaningful ...

LAST 30 PRESS RELEASES:

Slowed by sound: A mouse model of Parkinson’s Disease shows noise affects movement

Demographic shifts could boost drug-resistant infections across Europe

Insight into how sugars regulate the inflammatory disease process

PKU scientists uncover climate impacts and future trends of hailstorms in China

Computer model mimics human audiovisual perception

AC instead of DC: A game-changer for VR headsets and near-eye displays

Prevention of cardiovascular disease events and deaths among black adults via systolic blood pressure equity

Facility-based uptake of colorectal cancer screening in 45- to 49-year-olds after US guideline changes

Scientists uncover hidden nuclear droplets that link multiple leukemias and reveal a new therapeutic target

A new patch could help to heal the heart

New study shows people with spinal cord injuries are more likely to develop chronic disorders

Heat as a turbo-boost for immune cells

Jülich researchers reveal: Long-lived contrails usually form in natural ice clouds

Controlling next-generation energy conversion materials with simple pressure

More than 100,000 Norwegians suffer from work-related anxiety

The American Pediatric Society selects Dr. Harolyn Belcher as the recipient of the 2026 David G. Nichols Health Equity Award

Taft Armandroff and Brian Schmidt elected to lead Giant Magellan Telescope Board of Directors

FAU Engineering receives $1.5m gift to launch the ‘Ubicquia Innovation Center for Intelligent Infrastructure’

Japanese public show major reservations to cell donation for human brain organoid research

NCCN celebrates expanding access to cancer treatment in Africa at 2025 AORTIC Meeting with new NCCN adaptations for Sub-Saharan Africa

Three health tech innovators recognized for digital solutions to transform cardiovascular care

A sequence of human rights violations precedes mass atrocities, new research shows

Genetic basis of spring-loaded spider webs

Seeing persuasion in the brain

Allen Institute announces 2025 Next Generation Leaders

Digital divide narrows but gaps remain for Australians as GenAI use surges

Advanced molecular dynamics simulations capture RNA folding with high accuracy

Chinese Neurosurgical Journal Study unveils absorbable skull device that speeds healing

Heatwave predictions months in advance with machine learning: A new study delivers improved accuracy and efficiency

2.75-million-year-old stone tools may mark a turning point in human evolution

[Press-News.org] Risk of gastrointestinal adverse events associated with glucagon-like peptide-1 receptor agonists for weight loss
JAMA